Anti-Human CD140a Recombinant Antibody(Olaratumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD140a Recombinant Antibody(Olaratumab)

Anti-Human CD140a Recombinant Antibody(Olaratumab)

产品编号

YR1233

别名

科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Catalog Number	YR1233
Alias	科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab
Size	1mg, 5mg
Molecular Name	Olaratumab
CAS Number	1024603-93-7
Molecular Weight	154 kDa
Target	CD140a[Homo sapiens]
Antibody Isotype	IgG1 Kappa
Clonity	Monoclonal
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses").
Application	IF, IP, Neut, FuncS, ELISA, FCM
Remarks	This product is for research use only.

推荐产品

400-621-6806
18630936064（微信同号）
周一至周五 8:30-18:00
0